Search research articles
Contact Us
Filters
Showing results (391-400 of 399) with videos related to
Page
of 40
Sort By:
You have reached the last page of results.
This site can display upto 399 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2021
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium
Steven G DuBois, M Meaghan Granger, Susan Groshen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2025
Phase I Study of <sup>131</sup>I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
Thomas Cash, Araz Marachelian, Steven G DuBois, et al.
Haematologica
|
September 18, 2012
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe
Mehdi Nouraie, Janet S Lee, Yingze Zhang, et al.
Ebiomedicine
|
November 7, 2025
Genetic diagnostic yield by MRI pattern in children with cerebral palsy: a population-based study
Jesia G Berry, Ajay Taranath, Robert Goetti, et al.
Pediatric Blood & Cancer
|
April 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia
Seth E Karol, Seong L Khaw, C Michel Zwaan, et al.
Nature Medicine
|
April 3, 2023
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
Kelly C Goldsmith, Julie R Park, Kimberly Kayser, et al.
Communications Biology
|
April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
Karuna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Pediatric Blood & Cancer
|
June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum
Steven G DuBois, Lucas Moreno, John Anderson, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
April 30, 2022
Canadian Surgery Forum
H Atlas, N Safa, R Denis, et al.
Page
of 40
Search research articles
Search
Showing results (391-400 of 399) with videos related to
Sort By:
Page
of 40
You have reached the last page of results.
This site can display upto 399 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2021
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium
Steven G DuBois, M Meaghan Granger, Susan Groshen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2025
Phase I Study of <sup>131</sup>I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
Thomas Cash, Araz Marachelian, Steven G DuBois, et al.
Haematologica
|
September 18, 2012
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe
Mehdi Nouraie, Janet S Lee, Yingze Zhang, et al.
Ebiomedicine
|
November 7, 2025
Genetic diagnostic yield by MRI pattern in children with cerebral palsy: a population-based study
Jesia G Berry, Ajay Taranath, Robert Goetti, et al.
Pediatric Blood & Cancer
|
April 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia
Seth E Karol, Seong L Khaw, C Michel Zwaan, et al.
Nature Medicine
|
April 3, 2023
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
Kelly C Goldsmith, Julie R Park, Kimberly Kayser, et al.
Communications Biology
|
April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
Karuna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Pediatric Blood & Cancer
|
June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum
Steven G DuBois, Lucas Moreno, John Anderson, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
April 30, 2022
Canadian Surgery Forum
H Atlas, N Safa, R Denis, et al.
Page
of 40